AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Sacubitril Valsartan Sodium Hydrate
10 registrations across 2 African markets— 10 active
Markets with Sacubitril Valsartan Sodium Hydrate
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ENTRESTO 50 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| ENTRESTO 100 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| ENTRESTO 200 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| VYMADA 50 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| VYMADA 100 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| VYMADA 200 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| Uperio 100mg Film Coated Tablet | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| Uperio 200mg Film Coated Tablet | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| NEPRIVAS 97/103 Film Coated Tablet | 🇹🇿Tanzania | MSN Laboratories Private Limited | active | — |
| Uperio 50mg Film Coated Tablet | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
Sacubitril Valsartan Sodium Hydrate in Africa — Regulatory Overview
Sacubitril Valsartan Sodium Hydrate is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.